https://www.selleckchem.com/products/rg108.html
5 (SD 1.2) vs. VAS 2.4 (SD 2.2; P 0.001)], but this was not statistically significant at 24 months [VAS 0.7 (SD 1.4) vs. VAS 1.5 (SD 2.0; P = 0.11)]. Superficial skin infections were more frequent in the TSF group [22 (71%) vs. 4 (13%); P 0.001]. The number of other complications was similar between the groups. Both TSF and IMN provided good clinical results. TSF had more pin-track infections but less knee pain the first year. Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence. The
Like
Comment
Share
